Differentiated approach to the choice of therapy for stress urinary incontinence in women with pelvic floor dysfunction

Abstract

BACKGROUND: Among the symptoms of pelvic floor dysfunction, urinary incontinence is common in young patients. Stress urinary incontinence disrupts psychological health, sexual and social life. The effectiveness of modern conservative treatments for mild stress urinary incontinence in women of reproductive and perimenopausal age is being studied to prevent disease progression and improve the quality of life.

AIM: The aim of this study was a comparative assessment of the effectiveness of pelvic floor muscle training using the Tyulpan laser vaginal simulator and paraurethral injections of a high-density hyaluronic biopolymer for the correction of stress urinary incontinence in women of reproductive and perimenopausal age with pelvic floor dysfunction.

MATERIALS AND METHODS: We examined 82 patients aged 43.35 ± 6.25 years with mild to moderate stress urinary incontinence combined with grade I to II genital prolapse. After general clinical and special studies, including voiding diaries, Urgency Bother Visual Analogue Scale, cough test, ultrasound of the urethrovesical junction and pelvic floor, 41 women were prescribed a course of remote pelvic floor muscle training under medical supervision using the Tyulpan laser vaginal simulator (group I). 41 patients underwent paraurethral injection of 4.0 ml of high-density hyaluronic biopolymer crosslinked with 1,4-butanediol diglycidyl ether (group II). The effectiveness of therapy was evaluated one, six and 12 months after the start of treatment.

RESULTS: After one month, the absence of stress urinary incontinence episodes based on voiding diaries was found in 29.4% of patients in group I and in 85.4% of patients in group II (2.9 times more often) (p < 0.001); after 12 months, in 73.1% of patients in group I and in 36.4% of patients in group II (half as often) (p = 0.011). After one month, a negative cough test was detected in 65.0% of women in group I and in 92.1% of women in group II (1.4 times more often) (p = 0.023). After six months, the results of treatment for stress urinary incontinence based on the cough test were not different and amounted to 80.0% in group I and 71.9% in group II (p = 0.725). When assessing the pelvic floor muscle strength using the Oxford Scale and perineometry, an increase in strength after one and six months was detected in 100% of patients in group I (p < 0.001). Both techniques equally reduced urethral mobility as measured by ultrasound over the one-month follow-up. Pelvic floor muscle training more significantly improved the quality of life of women 12 months after the start of therapy (p < 0.05).

CONCLUSIONS: The introduction of high-density hyaluronic biopolymer leads to a rapid and pronounced positive result in the treatment of stress urinary incontinence and an improvement in the quality of life in the short term; it is recommended for patients interested in quickly achieving results, informed about the limited duration of the effect. Regular training of the pelvic floor muscles in biofeedback mode under the remote control of a doctor contributes to better results in the long term. This method is recommended for women who are able to contract the pelvic floor muscles and are ready for regular exercise.

Keywords

pelvic floor dysfunction / stress urinary incontinence / bulking agents / hyaluronic biopolymer / pelvic floor muscle training

References

[1] Peinado-Molina RA, Hernández-Martínez A, Martínez-Vázquez S, et al. Pelvic floor dysfunction: prevalence and associated factors. BMC Public Health. 2023;23(1):2005. doi: 10.1186/S12889-023-16901-3

[2] Peinado-Molina R.A., Hernández-Martínez A., Martínez-Vázquez S., et al. Pelvic floor dysfunction: prevalence and associ- ated factors // BMC Public Health. 2023. Vol. 23, N. 1. Р. 2005. doi: 10.1186/S12889-023-16901-3

[3] Alves JO, Da Luz ST, Brandão S, et al. Urinary incontinence in physically active young women: prevalence and related factors. Int J Sports Med. 2017;38(12):937–941. doi: 10.1055/S-0043-115736

[4] Alves J.O., Da Luz S.T., Brandão S., et al. Urinary incontinence in physically active young women: prevalence and related factors // Int J Sports Med. 2017. Vol. 38, N. 12. P. 937–941. doi: 10.1055/S-0043-115736

[5] Rusina EI. Mixed and combined with pelvic organ prolapse urinary incontinence in women: pathogenesis, diagnosis, treatment [dissertation abstract]. Saint Petersburg; 2015 [cited 27.03.2024]. Available from: https://www.dissercat.com/content/smeshannoe-i-sochetannoe-s-prolapsom-tazovykh-organov-nederzhanie-mochi-u-zhenshchin-patogen. (In Russ.) EDN: ZPVFXZ

[6] Русина Е.И. Смешанное и сочетанное с пролапсом тазовых органов недержание мочи у женщин: патогенез, диагностика, лечение: автореф. дис. ... доктора мед. наук. Санкт-Петербург, 2015. Режим доступа: https://www.dissercat.com/content/smeshannoe-i-sochetannoe-s-prolapsom-tazovykh-organov-nederzhanie-mochi-u-zhenshchin-patogen. Дата обращения: 27.03.2024. EDN: ZPVFXZ

[7] AlQuaiz AJM, Kazi A, AlYousefi N, et al. Urinary incontinence affects the quality of life and increases psychological distress and low self-esteem. Healthcare (Basel). 2023;11(12):1772. doi: 10.3390/HEALTHCARE11121772

[8] AlQuaiz A.M., Kazi A., AlYousefi N., et al. Urinary incontinence affects the quality of life and increases psychological distress and low self-esteem // Healthcare (Basel). 2023. Vol. 11, N. 12. Р. 1772. doi: 10.3390/HEALTHCARE11121772

[9] Sazonova NA, Kiseleva MG, Gadzhieva ZK, et al. Urinary incontinence in women and its impact on quality of life. Urologiia. 2022;(2):136–139. EDN: DUSNHR doi: 10.18565/urology.2022.2.136-139

[10] Сазонова Н.А., Киселева М.Г., Гаджиева З.К., и др. Недержание мочи у женщин и его влияние на качество жизни // Урология. 2022. № 2. С. 136–139. EDN: DUSNHR doi: 10.18565/urology.2022.2.136-139

[11] Grzybowska ME, Wydra D, Smutek J. Analysis of the usage of continence pads and help-seeking behavior of women with stress urinary incontinence in Poland. BMC Womens Health. 2015;15:80. doi: 10.1186/s12905-015-0238-6

[12] Grzybowska M.E., Wydra D., Smutek J. Analysis of the usage of continence pads and help-seeking behavior of women with stress urinary incontinence in Poland // BMC Womens Health. 2015. Vol. 15. P. 80. doi: 10.1186/s12905-015-0238-6

[13] Kim EK, Muñoz JM, Hong CX, et al. Variation in diagnosis of urinary incontinence in women by provider and patient demographic factors. World J Urol. 2023;41(3):821–827. doi: 10.1007/S00345-023-04309-Y

[14] Kim E.K., Muñoz J.M, Hong C.X, et al. Variation in diagnosis of urinary incontinence in women by provider and patient demographic factors // World J Urol. 2023. Vol. 41, N. 3. P. 821–827. doi: 10.1007/S00345-023-04309-Y

[15] Bezhenar VF, Rusina EI, Tsuladze LK, et al. Prognostic and predisposing risk factors for perinatal pathology in women with various forms of hyperhomocysteinemia. Journal of Obstetrics and Women’s Diseases. 2012;61(5):30–37. EDN: QBVSKN doi: 10.17816/JOWD61530-37

[16] Беженарь В.Ф., Русин Е.И., Цуладзе Л.К., и др. Эффективный клинический опыт использования субуретральных слингов в лечении недержания мочи у женщин // Журнал акушерства и женских болезней. 2012. Т. 61, № 5. С. 30–37. EDN: QBVSKN doi: 10.17816/JOWD61530-37

[17] Rusina EI, Zhevlakova MM, Yarmolinskaya MI. Stress urinary incontinence in women. Possibilities of conservative therapy. Journal of Obstetrics and Women’s Diseases. 2021;70(5):131–140. (In Russ.) EDN: CVVLOH doi: 10.17816/JOWD76029

[18] Русина Е.И, Жевлакова М.М., Ярмолинская М.И. Стрессовое недержание мочи у женщин. Возможности консервативной терапии // Журнал акушерства и женских болезней. 2021. Т. 70, № 5. С. 131–140. EDN: CVVLOH doi: 10.17816/JOWD76029

[19] Rusina YI. The role of complex preoperative urodynamic testing of continent women when planning surgery for pelvic organ prolapse. Journal of Obstetrics and Women’s Diseases. 2014;63(1):17–25. EDN: SEMVLN doi: 10.17816/JOWD63117-25

[20] Русина Е.И. Роль комплексного уродинамического исследования при планировании оперативного лечения у континентных женщин с пролапсом тазовых органов // Журнал акушерства и женских болезней. 2014. Т. 63, № 1. С. 17–25. EDN: SEMVLN doi: 10.17816/JOWD63117-25

[21] Russian Society of Urologists. Urinary incontinence. Clinical recommendations. 2020 [cited 13.12.2023]. Available from: http://disuria.ru/_ld/7/730_kr20N39p3R32mz.pdf (In Russ.)

[22] Российское общество урологов. Недержание мочи. Клинические рекомендации. 2020. Режим доступа: http://disuria.ru/_ld/7/730_kr20N39p3R32mz.pdf. Дата обращения: 13.12.2023.

[23] Krotova NO, Kuzmin IV, Ulitko TV. Biofeedback in treatment and rehabilitation of urinаry incontinence in women. Bulletin of Restorative Medicine. 2020;100(6):57–65. EDN: JXXAGE doi: 10.38025/2078-1962-2020-100-6-57-65

[24] Кротова Н.О., Кузьмин И.В., Улитко Т.В. Метод биологической обратной связи в лечении и реабилитации женщин с недержанием мочи // Вестник восстановительной медицины. 2020. Т. 100, № 6. С. 57–65. EDN: JXXAGE doi: 10.38025/2078-1962-2020-100-6-57-65

[25] Rusina EI, Zhevlakova MM. Remote pelvic floor muscle training in the treatment of stress urinary incontinence in women. Journal of Obstetrics and Women’s Diseases. 2023;72(3):105–115. EDN: ESHEYN doi: 10.17816/JOWD430311

[26] Русина Е.И., Жевлакова М.М. Дистанционные тренировки мышц тазового дна в лечении стрессового недержания мочи у женщин // Журнал акушерства и женских болезней. 2023. Т. 72, № 3. С. 105–115. EDN: ESHEYN doi: 10.17816/JOWD430311

[27] Serati M, Braga A, Salvatore S, et al. Up-to-date procedures in female stress urinary incontinence surgery: a concise review on bulking agents procedures. Medicina. 2022;58(6):776. doi: 10.3390/MEDICINA58060775

[28] Serati M., Braga A., Salvatore S., et al. Up-to-date procedures in female stress urinary incontinence surgery: a concise review on bulking agents procedures // Medicina. 2022. Vol. 58, N. 6. Р. 775. doi: 10.3390/MEDICINA58060775

[29] Serati M, Braga A, Caccia G, et al. TVT-O for treatment of pure urodynamic stress urinary incontinence: efficacy and adverse effects at 13-years follow-up. Neurourol Urodyn. 2020;39(5):1423–1429. doi: 10.1002/NAU.24358

[30] Serati M., Braga A., Caccia G., et al. TVT-O for treatment of pure urodynamic stress urinary incontinence: efficacy and adverse ef- fects at 13-years follow-up // Neurourol Urodyn. 2020. Vol. 39, N. 5. P. 1423–1429. doi: 10.1002/NAU.24358

[31] Rusina EI, Zhevlakova MM. Bulking agents for minimally invasive correction of stress urinary incontinence in women. Journal of Obstetrics and Women’s Diseases. 2021;70(4):115–124. EDN: ZAANEL doi: 10.17816/JOWD61994

[32] Русина Е.И., Жевлакова М.М. Объемообразующие вещества при малоинвазивной коррекции стрессового недержания мочи у женщин // Журнал акушерства и женских болезней. 2021. Т. 70, № 4. C. 115–124. EDN: ZAANEL doi: 10.17816/JOWD61994

[33] Tsukanov AYu, Mirzakadiev AA, Dunkurs AV. Bulking agents in case of treatment of female stress urinary incontinence. Urology Herald. 2020;8(2):99–106. EDN: BSFBIS doi: 10.21886/2308-6424-2020-8-2-99-106

[34] Цуканов А.Ю., Мирзакадиев А.А., Дункурс А.В. Объем-образующие вещества в лечении стрессового недержания мочи у женщин // Вестник урологии. 2020. Т. 8, № 2. C. 99–106. EDN: BSFBIS doi: 10.21886/2308-6424-2020-8-2-99-106

[35] Bezhenar VF, Arakelyan BV., Krutova VA, et al. Urethral bulking agents in the treatment of stress urinary incontinence. Kuban Scientific Medical Bulletin. 2019;26(4):84–93. EDN: FCEMLZ doi: 10.25207/1608-6228-2019-26-4-84-93

[36] Беженарь В.Ф., Аракелян Б.В., Крутова В.А., и др. Применение объемообразующих веществ в лечении стрессового недержания мочи // Кубанский научный медицинский вестник. 2019. Т. 26, № 4. С. 84–93. EDN: FCEMLZ doi: 10.25207/1608-6228-2019-26-4-84-93

[37] Zheleznyakova I. Optimization of treatment of stress urinary incontinence in women using extracorporeal magnetic stimulation [dissertation abstract]. Moscow; 2011 [cited 27.03.2024]. Available from: https://www.dissercat.com/content/optimizatsiya-lecheniya-stressovogo-nederzhaniya-mochi-u-zhenshchin-s-pomoshchyu-metoda-ekst. (In Russ.) EDN: QHHBPX

[38] Железнякова И.А. Оптимизация лечения стрессового недержания мочи у женщин с помощью метода экстракорпоральной магнитной стимуляции: автореф. дис. ... кандидат мед. наук. Москва, 2011. Режим доступа: https://www.dissercat.com/content/optimizatsiya-lecheniya-stressovogo-nederzhaniya-mochi-u-zhenshchin-s-pomoshchyu-metoda-ekst. Дата обращения: 27.03.2024. EDN: QHHBPX

[39] Chapple C, Dmochowski R. Particulate versus non-particulate bulking agents in the treatment of stress urinary incontinence. Res Rep Urol. 2019;11:299–310. doi: 10.2147/RRU.S220216

[40] Chapple C., Dmochowski R. Particulate versus non-particulate bulking agents in the treatment of stress urinary incontinence // Res Rep Urol. 2019. Vol. 11. P. 299–310. doi: 10.2147/RRU.S220216

[41] Fundarò SP, Salti G, Malgapo DMH, et al. The rheology and physicochemical characteristics of hyaluronic acid fillers: their clinical implications. Int J Mol Sci. 2022;23(18):10518. doi: 10.3390/ijms231810518

[42] Fundarò S.P., Salti G., Malgapo D.M.H., et al. The rheology and physicochemical characteristics of hyaluronic acid fillers: their clinical implications // Int J Mol Sci. 2022. Vol. 23, N. 18. doi: 10.3390/ijms231810518

[43] Galeeva AG. Local change in skin metabolism with intradermal injection of unstabilized hyaluronic acid in an experiment [dissertation abstract]. Ryazan; 2018 [cited 27.03.2024]. Available from: https://www.dissercat.com/content/lokalnye-izmeneniya-metabolizma-kozhi-pri-vnutridermalnom-vvedenii-nestabilizirovannoi-vysok. EDN: XSNMCD (In Russ.)

[44] Галеева А.Локальное изменение метаболизма кожи при внутридермальном введении нестабилизированной гиалуроновой кислоты в эксперименте: автореф. дис. ... кандидат мед. наук. Рязань, 2018. Режим доступа: https://www.dissercat.com/content/lokalnye-izmeneniya-metabolizma-kozhi-pri-vnutridermalnom-vvedenii-nestabilizirovannoi-vysok. Дата обращения 27.03.2024. EDN: XSNMCD

[45] Tsukanov AYu, Mirzakadiev AA, Dunkurs AV. The first experience of injecting of bulking agents in mild stress incontinence in reproductive age womens. Experimental and Сlinical Urology. 2020;12(2):158–163. EDN: DQTNIN doi: 10.29188/2222-8543-2020-12-2-158-163

[46] Цуканов А.Ю., Мирзакадиев А.А., Дункурс А.В. Первый опыт инъекционного введения объем-образующих веществ при стрессовом недержании мочи легкой степени у женщин репродуктивного возраста // Экспериментальная и клиническая урология. 2020. Т. 12, № 2. С. 158–163. EDN: DQTNIN doi: 10.29188/2222-8543-2020-12-2-158-163

[47] Rusina EI, Zhevlakova MM, Shelaeva EV, et al. Minimally invasive correction of stress urinary incontinence in women with pelvic floor dysfunction. Journal of Obstetrics and Women’s Diseases. 2024;73(1):51–66. doi: 10.17816/JOWD624506

[48] Русина Е.И., Жевлакова М.М., Шелаева Е.В., и др. Малоинвазивная коррекция стрессового недержания мочи при дисфункции тазового дна у женщин // Журнал акушерства и женских болезней. 2024. Т. 73, № 1. С. 51–66. doi: 10.17816/JOWD624506

[49] Zhevlakova MM, Rusina EI, Shelaeva EV, et al. The use of hyaluronic acid based bulking agent for stress urinary incontinence in women: a prospective controlled study. Gynecology. 2024;26(1):59–67. doi: 10.26442/20795696.2024.1.202623

[50] Жевлакова М.М., Русина Е.И., Шелаева Е.В., и др. Применение объемообразующего вещества на основе гиалуроновой кислоты при стрессовом недержании мочи у женщин // Гинекология. 2024. Т. 26, № 1. С. 59–57. doi: 10.26442/20795696.2024.1.202623

[51] Zhevlakova MM, Rusina EI. Stress urinary incontinence of mild severity in women of reproductive and perimenopausal age. In: Materials of the XXII All-Russian Scientific and Educational Forum “Mother and Child”. Krasnogorsk, September 29 – October 1, 2021. Moscow: MEDI Ekspo; 2021 [cited 27.03.2024]. Available from: https://www.mediexpo.ru/fileadmin/user_upload/content/pdf/thesis/md_2021_thesis.pdf (In Russ.)

[52] Жевлакова М.М., Русина Е.И. Стрессовое недержание мочи легкой степени тяжести у женщин репродуктивного и перименопаузального возраста. В кн.: Материалы XXII всероссийского научно-образовательного форума «Мать и дитя». Красногорск, 29 сентября – 1октября 2021 Москва: МЕДИ Экспо, 2021. С. 63. Режим доступа: https://www.mediexpo.ru/fileadmin/user_upload/content/pdf/thesis/md_2021_thesis.pdf. Дата обращения: 27.03.2024.

[53] Kan DV. Guide to obstetric and gynecological urology. Moscow; 1986. (In Russ.)

[54] Кан Д.В. Руководство по акушерской и гинекологической урологии. Москва: Медицина, 1986.

[55] Chechneva MA, Buyanova SN, Popova AA, et al. Ultrasound diagnosis of genital prolapse and urinary incontinence in women. Moscow: MEDpress-inform; 2016. (In Russ.)

[56] Чечнева М.А., Буянова С.Н., Попов А.А., и др. Ультразвуковая диагностика пролапса гениталий и недержания мочи у женщин. Москва: МЕДпресс-информ, 2016.

[57] Bø K, Sundgot-Borgen J. Are former female elite athletes more likely to experience urinary incontinence later in life than non-athletes? Scand J Med Sci Sports. 2010;20(1):100–104. doi: 10.1111/j.1600-0838.2008.00871.x

[58] Bø K., Sundgot-Borgen J. Are former female elite athletes more likely to experience urinary incontinence later in life than non-athletes? // Scand J Med Sci Sports. 2010. Vol. 20, N. 1. P. 100–104. doi: 10.1111/j.1600-0838.2008.00871.x

[59] Bø K. Pelvic floor muscle training in treatment of female stress urinary incontinence, pelvic organ prolapse and sexual dysfunction. World J Urol. 2012;30(4):437–443. doi: 10.1007/s00345-011-0779-8

[60] Bø K. Pelvic floor muscle training in treatment of female stress urinary incontinence, pelvic organ prolapse and sexual dysfunction // World J Urol. 2012. Vol. 30, N. 4. P. 437–443. doi: 10.1007/s00345-011-0779-8

[61] Bourcier AP, Juras JC. Nonsurgical therapy for stress incontinence. Urologic Clinics of North America. 1995;22(3):613–627.

[62] Bourcier A.P., Juras J.C. Nonsurgical therapy for stress incontinence // Urologic Clinics of North America. 1995. Vol. 22, N. 3. P. 613–627.

[63] Chmielewska D, Stania M, Kucab–Klich K, et al. Electromyographic characteristics of pelvic floor muscles in women with stress urinary incontinence following sEMG-assisted biofeedback training and Pilates exercises. PLoS One. 2019;14(12). doi: 10.1371/JOURNAL.PONE.0225647

[64] Chmielewska D., Stania M., Kucab–Klich K., et al. Electromyographic characteristics of pelvic floor muscles in women with stress urinary incontinence following sEMG-assisted biofeedback training and Pilates exercises // PLoS One. 2019. Vol. 14, N. 12. doi: 10.1371/JOURNAL.PONE.0225647

[65] Hui E, Lee PSC, Woo J. Management of urinary incontinence in older women using videoconferencing versus conventional management: a randomized controlled trial. J Telemed Telecare. 2006;12(7):343–347. doi: 10.1258/135763306778682413

[66] Hui E., Lee P.S.C., Woo J. Management of urinary incontinence in older women using videoconferencing versus conventional management: a randomized controlled trial // J Telemed Telecare. 2006. Vol. 12, N. 7. P. 343–347. doi: 10.1258/135763306778682413

[67] Hoe V, Haller B, Yao HH, et al. Urethral bulking agents for the treatment of stress urinary incontinence in women: a systematic review. Neurourol Urodyn. 2021;40(6):1349–1388. doi: 10.1002/NAU.24696

[68] Hoe V., Haller B., Yao H.H., et al. Urethral bulking agents for the treatment of stress urinary incontinence in women: a system- atic review // Neurourol Urodyn. 2021. Vol. 40, N. 6. P. 1349–1388. doi: 10.1002/NAU.24696

[69] Apolikhina IA, Saidova AS, Makhmedzhanova FN. Use of volume-forming drugs to treat female stress urinary incontinence. Obstetrics and Gynecology. 2011;(7–1):21–24. EDN: PFTVBX

[70] Аполихина И.А., Саидова А.С. Махмеджанова Ф.Н. Применение объемообразующих средств в лечении стрессового недержания мочи у женщин // Акушерство и гинекология. 2011. Т. 7–1. С. 21–24. EDN: PFTVBX

[71] Elzayat EA, Karsenty G, Bismar TA, et al. Volume changes and histological response to injected dextranomer/hyaluronic acid copolymer (Zuidex) and collagen (Contigen) in rats. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(2):247–252. doi: 10.1007/s00192-007-0414-9

[72] Elzayat E.A., Karsenty G., Bismar T.A., et al. Volume changes and histological response to injected dextranomer/hyaluronic acid copolymer (Zuidex) and collagen (Contigen) in rats // Int Urogynecol J Pelvic Floor Dysfunct. 2008. Vol. 19, N. 2. P. 247–252. doi: 10.1007/s00192-007-0414-9

RIGHTS & PERMISSIONS

Eсо-Vector